Investigation of pathways of advanced glycation end-products accumulation in macrophages

Molecular Nutrition and Food Research

Volumn 51, Issue 4, 2007, Pages 462-467

  Nagai, Ryoji ^a   Fujiwara, Yukio ^a   Mera, Katsumi ^a   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Advanced glycation end product; Macrophage; N (carboxymethyl)lysine; Scavenger receptor

Indexed keywords

MURINAE;

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCTS BOVINE SERUM ALBUMIN; ADVANCED GLYCATION END PRODUCTS HUMAN SERUM ALBUMIN; ADVANCED GLYCATION END PRODUCTS-BOVINE SERUM ALBUMIN; ADVANCED GLYCATION END PRODUCTS-HUMAN SERUM ALBUMIN; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; BOVINE SERUM ALBUMIN; GLUCOSE; HYPOCHLOROUS ACID; IMMUNOGLOBULIN RECEPTOR; RADIOACTIVE IODINE; SERUM ALBUMIN; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; ENDOCYTOSIS; HUMAN; MACROPHAGE; MASS SPECTROMETRY; METABOLISM; MOUSE;

ANIMALS; CELL LINE; ENDOCYTOSIS; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPOCHLOROUS ACID; IODINE RADIOISOTOPES; MACROPHAGES; MICE; RECEPTORS, IMMUNOLOGIC; SERUM ALBUMIN; SERUM ALBUMIN, BOVINE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34447500546     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200600255     Document Type: Conference Paper

References (25)

1. Vlassara, H., Bucala, R., Striker, L., Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab. Invest. 1994, 70, 138-151.
2. Suzuki, H., Kurihara, Y., Takeya, M., Kamada, N. et al., A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection, Nature 1997, 386, 292-296.
3. Nagai, R., Matsumoto, K., Ling, X., Suzuki, H. et al., Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor, Diabetes 2000, 49, 1714-1723.
4. Ohgami, N., Nagai, R., Ikemoto, M., Arai, H. et al., Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products, J. Biol. Chem. 2001, 276, 3195-3202.
5. Ohgami, N., Nagai, R., Miyazaki, S., Ikemoto, M. et al., Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products, J. Biol. Chem. 2001, 276, 13348-13355.
6. Jono, T., Miyazaki, A., Nagai, R., Sawamura, T. et al., Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE), FEBS Lett. 2002, 511, 170-174.
7. Hansen, B., Svistounov, D., Olsen, R., Nagai, R. et al., Advanced glycation end products impair the scavenger function of rat hepatic sinusoidal endothelial cells, Diabetologia. 2002, 45, 1379-1388.
8. Tamura, Y., Adachi, H., Osuga, J., Ohashi, K. et al., FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products, J. Biol. Chem. 2003, 278, 12613-12617.
9. Schmidt, A. M., Vianna, M., Gerlach, M., Brett, J. et al., Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface, J. Biol. Chem. 1992, 267, 14987-14997.
10. Neeper, M., Schmidt, A. M., Brett, J., Van, S. D. et al., Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins, J. Biol. Chem. 1992, 267, 14998-15004.
11. Araki, N., Higashi, T., Mon, T., Shibayama, R. et al., Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction, Eur. J. Biochem. 1995, 230, 408-415.
12. Saishoji, T., Higashi, T., Ikeda, K., Sano, H. et al., Advanced glycation end products stimulate plasminogen activator activity via GM-CSF in RAW 264.7 cells, Biochem. Biophys. Res. Commun. 1995, 217, 278-285.
13. Higashi, T., Sano, H., Saishoji, T., Ikeda, K. et al., The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells, Diabetes 1997, 46, 463-472.
14. Jinnouchi, Y., Sano, H., Nagai, R., Hakamata, H. et al., Glycolaldehyde-modified low density lipoprotein leads macrophages to foam cells via the macrophage scavenger receptor, J. Biochem. (Tokyo) 1998, 123, 1208-1217.
15. Shinohara, M., Thornalley, P. J., Giardino, I., Beisswengerm P. et al., Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis, J. Clin. Invest. 1998, 101, 1142-1147.
16. Nishikawa, T., Edelstein, D., Du, X.L., Yamagishi, S. et al., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, Nature 2000, 404, 787-790.
17. ε-(carboxyethyl)lysine, one of the methylglyoxal-derived AGE structures, in glucose-modified protein: mechanism for protein modification by reactive aldehydes, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003, 788, 75-84.
18. ε-(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite, Diabetes 2002, 51, 2833-2839.
19. Nagai, R., Hayashi, C.M., Xia, L., Takeya, M. et al., Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins, J. Biol. Chem. 2002, 277, 48905-48912.
20. ε-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction, Biochemistry 1996, 35, 8075-8083.
21. Thornalley, P.J., Argirova, M., Ahmed, N., Mann, V.M. et al., Mass spectrometric monitoring of albumin in uremia, Kidney Int. 2000, 55, 2228-2234.
22. Hammes, H., Du, X., Edelstein, D., Taguchi, T. et al., Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy, Nat. Med. 2003, 9, 294-299.
23. Babaei-Jadidi, R., Karachalias, N., Kupich, C., Ahmed, N. et al., High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats, Diabetologia 2004, 47, 2235-2246.
24. Sakurai, T., Sugioka, K., Nakano, M., O2- generation and lipid peroxidation during the oxidation of a glycated polypeptide, glycated polylysine, in the presence of iron-ADP, Biochem. Biophys. Acta 1990, 1043, 27-33.
25. ε-(carboxymethyl)lysine formation from Amadori product, Biochem. Biophys. Res. Commun. 1997, 234, 167-172.